NCT01142388 2026-05-29Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting94 enrolled 8 charts